… medications are used incorrectly or inconsistently, HIV can … over time. Combination pills containing tenofovir disoproxil fumarate … Drug Classes Mutations conferring resistance to the NNRTI rilpivirine … (in Cabenuva for HIV treatment and Apretude for PrEP …

… HIV/AIDS, integrase strand transfer inhibitors, T. marneffei, drug resistance, treatment … Group SoID, Chinese Medical Association; Chinese Center … #47;emtricitabine/rilpivirine single-tablet regimen. J … trial of itraconazole or amphotericin B for HIV- …

… statin and the dose should be carefully selected considering drug-drug … the antiretrovirals atazanavir and rilpivirine, which depend on … -cell proliferation, diminished vaccine responses, and increased … Practices for the Treatment of HIV Infection. Centers for …

… with the United Nations-backed Medicines Patent Pool (MPP) … who are virally suppressed. Rilpivirine, which was developed by … approved by the FDA as an HIV treatment in 2011 and already … which allowed specified generic drugmakers to produce their versions …

… long-acting injectable cabotegravir + rilpivirine as an HIV treatment option. Existing generic licensees … deeper and broader interest in HIV and AIDS than any company has … to deliver effective and innovative medicines for HIV treatment and prevention, as well …

… Medical Center and a director of the Tennessee Center of AIDS … that HBV screening and vaccination rates remain low. Currently … cabotegravir (CAB) and rilpivirine (RPV) for HIV treatment; however, CAB and … anesthesia in a normal doctor';s office by …

… After Merck, Chinese Biotech Hengrui Pharma Collaborates With … of its Specialty Medicines and Vaccines divisions, coupled … acting injectable HIV treatment combining cabotegravir and rilpivirine, to be … potential effects of pharmaceutical product imports on …

… Healthcare, a company focused on HIV medicines and majority owned by GSK … and Shionogi as shareholders, and Medicines Patent Pool, extending their voluntary … + rilpivirine as an HIV treatment option, the report said. [Read more: Aurobindo receives FDA …

… HIV elected to switch to long-acting injectable Vocabria + Rekambys (cabotegravir + rilpivirine … MBChB, MFPM, chief medical officer at ViiV Healthcare … trial is evaluating two 2-drug regimens for HIV-1 treatment … REKAMBYS FROM DAILY PILLS AFTER ACHIEVING RAPID …

… of Cabenuva (cabotegravir and rilpivirine) has found that … presented at the International AIDS Society meeting in Kigali … to capture demographics, medical and treatment history, and clinical outcomes … continue with trials for this version. A trial of the …